other steroid preparatton at the lirlie of observation eg. nasal sprays: not on regular oral steroids thoueh, rarelv. some had short courses to deal with exacerbations of measured by a single trained observer on a wall-mounted atadiometer over a peliod of 6 to 18 months: reponed dose of steroid uken at each appointment and averaged for the pertod of observation. Kf~lrlrs -Multiple regression analysis demonstrates that both height velocity was reduced in both groups (mean I-1VSDS for group receiving beclotnethasone -0.775: for froup receiving budesonide -0.35). The effect is sirnificantlv more marked with beclomethasone (n<0.05). 
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CORTICAL AURENAL TJMORS I N 1NFANCY:PRCGNOSTIC VALUE OF PCIlA/CYCLIIi VERSUS RIMOR WEIGHT. I . Bergads, S. Maylio, H. Chemes & C. Bergadi. D i v l s l o n o f Endocrinology, H o s p l t a l d e NlRos R. G u t i C r r e z , A r g e n t l n a .
Controversy e x l s t s to d e t e m n e ivhlch v a r l a b l e 1s a r e l l a b l e p r ed~c t o r o f c l i n l c a l outcome o f a d r e c o r t l c a l tumors I n children. We a n a l y z e d retrospectively 17 p a t l e n t s w i t h f u n c t i o n a l a d r e n a l tumors, and a s s e s s e d t h e l r c l l n i c a l outcome by comparing tumor w e l g h t , c l a s s~ c a l h l s t o l c g l c f e a t u r e s a n d p e r c e n t a g e o f p r o l i f e r a t i n g c e l l n u c l e a r a n t i g e n lPCNAl/cyclln I n t h e i r tumor c e l l s I n o r d e r t o delineate whlch v a r l a b l e c o r r e l a t e s b e s t w i t h c l l n l c a l outcome. Ten p a t l e n t s had Cushing Syndrome a n d 7 a p u r e V l r l l i z l n g Syndrome. Mean a g e a t diagnosis was 5.5+4.3 y e a r s ( r a n g e 0.4-14). T h r r t e e n p a t r e n t s w l t h a benign c o u r s e h a v e been f o l l o w e d f o r 10.124.3 y e a r s ( r a n g e 3.5-18). A l l t h e s e p a t l e n t s b u t one1185 g r ) had a t m r w e l g h t o f l e s s t h a n 100 gr(mean 6 0 . 8~5 2 g r ) . TWO p a t l e n t s had a m l l g n a n t c o u r s e , o n e d l e d 5 nwnths a f t e r s u r g e r y w l t h m e t a s t a s l s a n d t h e o t h e r p r e s e n t e d l u n g m e t a s t a s l s 1 8 m n t h s a f t e r s u r g e r y . T h e l r tumor w e i g h t s were 1000 a n d 780 g r respectively. A l l t h e h l s t o l o g y p a r a m e t e r s s u c h a s c e l l ul a r pleomorfism.neocros~s,calclf~catlons,capsular a n d v a s c u l a r i n v as l o n , were randomly found I n a l l p a t i e n t s a n d d l d n o c o r r e l a t e w l t h c l l n i c a l outcome. I n t h e former 1 3 p a t l e n t s s t a i n l n g w i t h PCNA/cyclin was found I n 16225% o f the tumor c e l l s l m e d i a n = 1 5 , ranqe=O to 9 0 % ) ; t h e two who had m l i g n a n t c o u r s e had v a l u e s o f 60 and 70%. Lle found a p s i t l v e c o r r e l a t l o n between tumor w e i g h t and PCNA/cyclln(r=0.60, p=0.0151. Our d a t a shows t h a t PCNA/cyclin c o u l d b e a f u r t h e r a l d t o p r e d l c t c l i n l c a l b e h a v i o r on t h e s e I n f r e q u e n t tumors a l t h o u g h t t h e c c c a s l o n a l p r e s e n c e o f smll t m r s w l t h high PCtdA/cyclin v a l u e s , ~n d i c a t e s t h a t t h i s p a r a m e t e r s h o u l d n o t b e used a l o n e . 
Quesada a n d C. Berqadi. Divisions o f Endocrinology and Urology, H o s p i t a l d e Nliios R. G u t l b r r e z , Buenos A l r e s , A r g e n t i n a . F i f t y two p a t l e n t s w l t h unilateral v n r i c o c e l e , aged 8 t o 1 9 y e a r s were s t u d l e d a n d grouped I n 5 Grades o f Puberty. B a s a l p l a s m t e s t o st e r o n e ( T ) , LH a n d FSH k f o r e and a f t e r GnRH a d r m n l s t r a t l o n were meas u r e d I n a l l p a t i e n t s . T e s t l c u l a r h l s t o l o g y was s t u d

